Associate Professor
Strategic program(s):
Biography
Dr. Debby Gawlitta is an Associate Professor working on maxillofacial tissue regeneration, particularly focusing on bone regeneration. She is inspired by the natural mechanisms of the body for bone development and repair that she aims to adopt in her regenerative strategies. Translation of the regenerative strategies to clinical practice is driving current research.
Dr. Gawlitta aims to mimic the process of endochondral bone regeneration (via a cartilage intermediate - such as seen in the growth plate) to ultimately restore defects in patients. Recently, she showed the potential of allogeneic cells (cells from donors) in this regenerative approach and currently studies the impact of the interaction with the immune system, devitalization and avenues for scale-up and clinical translation (see also here). The use of allogeneic cells would ease therapeutic interventions in patients. Furthermore, her group is focusing on vascularization strategies for bone regeneration to be able to create engineered bone tissue that is large enough to treat patient defects.
Research keywords include bone regeneration, cartilage, vascularization, clinical translation, biomaterials, stem/progenitor cells (MSCs, ECFCs, DPSCs), osteoimmunology, bioreactors, and 3D bioprinting.
***
Dr. Gawlitta was trained as a biomedical engineer at the Eindhoven University of Technology. Her PhD thesis was focused on generating engineered skeletal muscle tissue to model and monitor the development of pressure ulcers.
In 2007, she moved to the department of Orthopaedics, University Medical Center in Utrecht, to work on bone and cartilage tissue regeneration within the Hospital's strategic impulse on regenerative medicine. During this postdoctoral period, she received a prestigious Veni grant (Dutch innovation grant) to pursue (endochondral) bone regeneration from a cartilage template with bone marrow-derived stem cells.
In 2014, she moved to the department of 'Oral and Maxillofacial Surgery & Special Dental Care' to establish her own group focusing on craniomaxillofacial bone regeneration. She currently holds a position as Associate Professor, supervising her group in the RMCU (Regenerative Medicine Center Utrecht). In 2016, she received a start-up grant from the AO Foundation and in 2021 she received an OTP grant from NWO to extend and continue her endochondral research line in the XLbone project. She has published over 75 peer-reviewed papers. She is also taking part in large national consortia, such as the 'Zwaartekracht' Program on 'Materials-driven Regeneration' and the SUMMIT 'Drive-RM'.
Further, Debby Gawlitta developed and coordinated the 2-year Master’s program RMT – Regenerative Medicine and Technology (2012-2025), which is a collaborative program of the UMCU, Utrecht University and Eindhoven University of Technology. In 2025 she was appointed Director of the PhD program 'Regenerative Medicine'.
2025- present Director PhD program 'Regenerative Medicine' at the Graduate School of Life Sciences, Utrecht
2024- present Council member TERMIS-EU (Tissue Engineering and Regenerative Medicine International Society)
2023-present Board member NBTE (Dutch society for Biomaterials and Tissue Engineering)
2019-present Member executive committee of Strategic Research Program ‘Regenerative Medicine and Stem Cells’, UMC Utrecht
2019-present Member of the internationalization committee of the UMC Utrecht
2022-2025 MDR Young Talent Committee
2012-2025 Coordinator of Master's program 'Regenerative Medicine and Technology'
2010-present Teaching of various annual Bachelor, Master’s, PhD and Summer school lectures in the Biomedical Sciences, Veterinary Sciences, and Medicine curricula on e.g. Biomechanics, Bone Tissue Engineering and Bioreactors.
Reviewer for several journals, including Tissue Engineering, Biofabrication, Biomaterials, Biomedical Materials Research
-----------------------------
Former Member of the UMC Utrecht Young Academy
Member of the local organizing committee of the ESB 2018 (annual meeting of the European Society for Biomaterials)
Former Board Member NVMB (Dutch Society for Matrix Biology)
Research aim
Our team aims to regenerate maxillofacial bone defects via bio-inspired techniques. We combine stem cells, materials and/or bioengineering technologies to recapitulate natural bone tissue development and healing.
Go to group2024: TKI/HealthHolland grant 'Wishing Table', (co-applicant, €800,000)
2024: ZonMW (Care Research Netherlands & Medical Sciences of Dutch Research Council) Open competition grant ‘NutriBone’, (lead applicant, €790,000)
2023: RegMed XB/Strategic Vascular Alliance Valorisation Voucher (€25,000)
2022: NWO-TTW Open Technology Program 'Bridging the gap: aXelerated Large bone defect healing (XLbone)' No. 19260 (€ 839,935)
2018: H2020-MSCA-COFUND 'RESCUE' No. 801540 (co-applicant, € 3M)
2017: NWO Gravitation program 'MDR: Materials-driven research' (faculty member, € 18.8M)
2017: AO grant (AOCMF-17-17G) ‘MACRON: Mandibular Condyle Regeneration’ (€ 350,000)
2016: AO Foundation start-up grant (S-16-130G) ‘Clinical translation of endochondral bone regeneration’ (€ 107,000)
2016: Selected for the Research Talent Program of the UMC Utrecht
2014: Internal grant of UMC Utrecht for translational research (€ 33,300)
2013: NWO (Dutch Science Foundation) Graduate Program grant (€ 800,000)
2012: Selected for the Steyn Parvé program for stimulation of excellent female scientists of UMC Utrecht
2010: Veni: personal innovational incentive grant entitled ‘Mimicking nature: growing bone from cartilage’ was awarded by STW (Dutch technology foundation) (€250,000)
2008: Award for best thesis at the faculty of Biomedical Engineering at the Eindhoven University of Technology
2000: Award for internship at foreign institute (Eindhoven University of Technology)
